Skip to main content
. 2012 Jun 27;14(4):677–687. doi: 10.1208/s12248-012-9383-0

Fig. 5.

Fig. 5

Aprepitant plasma concentration vs. time profiles in fasted male beagle dogs following administration of aprepitant formulations at a dose of 2 mg/kg. The nanosuspension formulation resulted in a significant (4.3-fold) increase in AUC over the conventional suspension of micronized API and matched the exposures of a liquid-filled capsule (lipid/surfactant) formulation